PROTXX: Wearable device that improves the lives of those with complex neurological conditions

1

Invented 1 minute non-invasive test that identifies and quantifies neuromotor and neurosensory impairments

2

PAAS model enhances management and treatment of concussions, stroke, Parkinson's, multiple sclerosis

3

Our solution is commercially available with over 20 customers and pilots in U.S., Canada, U.K., Japan

4

We reduce time, travel, and costs for patients through remote patient monitoring

5

Institute of Health Economics set value-based pricing of $5,000 per patient per month for PROTXX

6

Partnered with machine learning and neurophysiology leaders to develop predictive diagnostics

John RalstonCEO and Founder

2016 “Pioneer in Healthcare Technology Innovations Award” CEO, Sales & Marketing, R&D at 8 previous Silicon Valley companies (2 IPOs, 8 M&A exits) MIT BSc, Cornell PhD, MIT Sloan MBA/MOT

I founded PROTXX to address the challenges encountered by clinical neurology and sports medicine providers treating young athletes with sports-related neurological disruptions, after my youngest daughter was forced to stop playing soccer following 2 severe concussions. Related clinical applications now include stroke, MS, and Parkinson's disease.

Joshua RoperVice President, Operations

GM, Product Executive, and Technology Leader experienced in Software, Hardware, Networking, Security, and IoT with more than 27M networked devices deployed and well over $2B in revenue

PROTXX

Wearable device that improves the lives of those with complex neurological conditions

Highlights

Our Team

Pitch

Downloads